Found: 764
Select item for more details and to access through your institution.
Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Discordance between prenatal cytogenetic diagnosis and outcome of pregnancy.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Best medical practice is important--whatever it is.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Trying to judge what is best medical practice.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Coping with regional variations: the case of surgery in Denmark.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Survival in breast cancer patients after the first episode of hypercalcaemia.
- Published in:
- 1998
- By:
- Publication type:
- journal article
FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2020, v. 277, n. 2, p. 539, doi. 10.1007/s00405-019-05684-2
- By:
- Publication type:
- Article
Understanding the Mechanisms Underlying Gambling Behaviour and Sleep.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Biological effects of fruit and vegetables.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Embryo quality and developmental potential is compromised by age.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGAE[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 252, doi. 10.2967/jnumed.122.264383
- By:
- Publication type:
- Article
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1871, doi. 10.2967/jnumed.122.264068
- By:
- Publication type:
- Article
Prospective phase II trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT imaging of integrin α<sub>v</sub>β<sub>3</sub> for prognostication in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264383
- By:
- Publication type:
- Article
First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264068
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
Prospective phase II trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT imaging of integrin αvβ3 for prognostication in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264068
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnost.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264068
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264068
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244509
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression2 free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244509
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression - free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244509
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression2 free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244509
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.244509
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.244509
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.24014
- By:
- Publication type:
- Article
Effect of selective I<sub>K,ACh</sub> inhibition by XAF-1407 in an equine model of tachypacing-induced persistent atrial fibrillation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Diabetes incidence and long-term exposure to air pollution: a cohort study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Using spatial context to support prospective memory in simulated air traffic control.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase II study of uPAR-PET/CT for staging of primary breast cancer in comparison with ultrasound and fine needle biopsies.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-77072-8
- By:
- Publication type:
- Article
Comparing DAPSA, DAPSA28, and DAS28‐CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 11, p. 1558, doi. 10.1002/acr.25396
- By:
- Publication type:
- Article
RECONCILIATION...REALLY? FROM MACDONALD TO HARPER: A LEGACY OF COLONIAL VIOLENCE.
- Published in:
- West Coast Line, 2012, v. 46, n. 2, p. 40
- By:
- Publication type:
- Article
PET/MRI in cancer patients: first experiences and vision from Copenhagen.
- Published in:
- MAGMA: Magnetic Resonance Materials in Physics, Biology & Medicine, 2013, v. 26, n. 1, p. 37, doi. 10.1007/s10334-012-0357-0
- By:
- Publication type:
- Article
CURRENT KNOWLEDGE AND CONSIDERATIONS REGARDING SURVEY REFUSALS.
- Published in:
- Public Opinion Quarterly, 2015, v. 79, n. 2, p. 411, doi. 10.1093/poq/nfv025
- By:
- Publication type:
- Article
Development and internal validation of a diagnostic prediction model for psoriasis severity.
- Published in:
- Diagnostic & Prognostic Research, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41512-023-00141-5
- By:
- Publication type:
- Article